[1]
2023. L-Ornithine-L-Aspartate and Intermittent Renal Replacement Therapy in Fulminant Hepatitis A: A Case Report. Journal of Renal and Hepatic Disorders. 7, 1 (Mar. 2023), 28–33. DOI:https://doi.org/10.15586/jrenhep.v7i1.154.